OUR MISSION is to serve pharmaceutical clients that provide cures and treatments for gastro-entrological diseases including: gallstones, PBC, PSC and NASH.

ABOUT ICE GROUP

ICE Group is a globally integrated business that produces ingredients for the pharmaceutical industry. Our main product is Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver conditions.

Founded more than sixty years ago, ICE Group is a global leader in bile-related products, with a network of specialist facilities around the world.

1949

ICE’s first plant was opened in Reggio Emilia, Italy (production of Cholic Acid and bile acids derivatives)
1996

BBA Industria Quimica (former Opoterapica) founded in Paranà, Brazil (collection of ox bile and its transformation in raw Cholic Acid)
1999

Acquisition of RPT Texas, USA (collection and concentration of ox bile)
2003

Opening of Arennis in Argentina (collection and concentration of ox bile)
2004

Opening of Walfed Pty in Australia (collection and concentration of ox bile)
2008

Acquisition of PCA, a major manufacturer of UDCA and derivative in Italy

Opening of PBP in Paraguay (collection and concentration of ox bile)
2010

Opening of CVF in Uruguay (collection and concentration of ox bile)
2014

Opening of the Des Moines plant in the USA (collection and concentration of pig bile)
2015

Acquisition of RIAZ in Italy (collection and concentration of ox bile and pig bile)
2016

Opening of Raichem (a 50% Joint Venture started in India)
2018

Raichem becomes a fully owned subsidiary
2019

Advent International acquires ICE Group

OUR HISTORY

ICE Group was established in 1949 by husband-and-wife team Dr Walter and Ida Bartoli. From our humble origins in Northern Italy, we have grown organically and through acquisitions into the company we are today.

Our Footprint

We have a vertically integrated model from sourcing to pharma grade production.

BILE
COLLECTION

Europe, US, Latin America, South
Africa, India, Australia

CHOLIC ACID
PRODUCTION

Brazil

API
PRODUCTION

Italy, India

Our facilities

As well as being the number-one player in the manufacture of UDCA, we also produce a comprehensive range of bile acid derivatives as well as other products we have developed.